EP3233063A4 - Régimes posologiques en trois phases pour l'administration d'antibiotiques en fonction du temps et dispositifs associés - Google Patents

Régimes posologiques en trois phases pour l'administration d'antibiotiques en fonction du temps et dispositifs associés Download PDF

Info

Publication number
EP3233063A4
EP3233063A4 EP15870990.7A EP15870990A EP3233063A4 EP 3233063 A4 EP3233063 A4 EP 3233063A4 EP 15870990 A EP15870990 A EP 15870990A EP 3233063 A4 EP3233063 A4 EP 3233063A4
Authority
EP
European Patent Office
Prior art keywords
administration
devices
same
time
dosing regimens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP15870990.7A
Other languages
German (de)
English (en)
Other versions
EP3233063A2 (fr
Inventor
Pieter Muntendam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ScPharmaceuticals Inc
Original Assignee
ScPharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ScPharmaceuticals Inc filed Critical ScPharmaceuticals Inc
Publication of EP3233063A2 publication Critical patent/EP3233063A2/fr
Publication of EP3233063A4 publication Critical patent/EP3233063A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0097—Micromachined devices; Microelectromechanical systems [MEMS]; Devices obtained by lithographic treatment of silicon; Devices comprising chips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
EP15870990.7A 2014-12-18 2015-12-16 Régimes posologiques en trois phases pour l'administration d'antibiotiques en fonction du temps et dispositifs associés Withdrawn EP3233063A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462093469P 2014-12-18 2014-12-18
PCT/US2015/066112 WO2016100523A2 (fr) 2014-12-18 2015-12-16 Régimes posologiques en trois phases pour l'administration d'antibiotiques en fonction du temps et dispositifs associés

Publications (2)

Publication Number Publication Date
EP3233063A2 EP3233063A2 (fr) 2017-10-25
EP3233063A4 true EP3233063A4 (fr) 2018-05-30

Family

ID=56127845

Family Applications (1)

Application Number Title Priority Date Filing Date
EP15870990.7A Withdrawn EP3233063A4 (fr) 2014-12-18 2015-12-16 Régimes posologiques en trois phases pour l'administration d'antibiotiques en fonction du temps et dispositifs associés

Country Status (3)

Country Link
EP (1) EP3233063A4 (fr)
AU (1) AU2015364677A1 (fr)
WO (1) WO2016100523A2 (fr)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8357394B2 (en) * 2005-12-08 2013-01-22 Shionogi Inc. Compositions and methods for improved efficacy of penicillin-type antibiotics
AU2007255338A1 (en) * 2006-06-08 2007-12-13 Ethypharm Improved method of treatment of bacterial infections

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Å. MYGLAND ET AL: "EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis", EUROPEAN JOURNAL OF NEUROLOGY, vol. 17, no. 1, 1 January 2010 (2010-01-01), pages 8 - e4, XP055201892, ISSN: 1351-5101, DOI: 10.1111/j.1468-1331.2009.02862.x *
DELPHINE CROISIER-BERTIN ET AL: "ABSTRACT", ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, vol. 55, no. 7, 16 May 2011 (2011-05-16), pages 3557 - 3563, XP055467199, ISSN: 0066-4804, DOI: 10.1128/AAC.01773-09 *

Also Published As

Publication number Publication date
WO2016100523A3 (fr) 2016-08-18
EP3233063A2 (fr) 2017-10-25
WO2016100523A2 (fr) 2016-06-23
AU2015364677A1 (en) 2017-07-27

Similar Documents

Publication Publication Date Title
IL251441A0 (en) History of imidazo pyridine and pharmaceutical preparations containing them
EP3463248A4 (fr) Dispositifs et procédés d'utilisation de dispositifs d'administration de médicament
EP3131544A4 (fr) Inhibiteurs de hdac et méthodes thérapeutiques les utilisant
EP3178059A4 (fr) Dispositifs médicaux et gestion de mise à jour de configuration
EP3125866A4 (fr) Dispositifs rechargeables d'administration de médicaments, et procédés pour leur utilisation
EP3354306A4 (fr) Dispositif d'administration de médicament et unité d'administration de médicament
EP3225619A4 (fr) Composé 2-aminopyrimidine et composition pharmaceutique et utilisation associées
EP3101015A4 (fr) Dérivé de sulfonamide hétérocyclique et médicament le contenant
IL271226A (en) medical preparation
EP3233111A4 (fr) Composition pharmaceutique comprenant du plasminogène et ses utilisations
EP3219344A4 (fr) Dispositif d'administration de solution de médicament
EP3124066A4 (fr) Dispositif d'administration de médicament liquide
ZA201602342B (en) Estate planning and administration
EP3185873A4 (fr) Composition pharmaceutique et procédés
AU2016218074B2 (en) Pharmaceutical formulation
HK1232211A1 (zh) 二甲基吡啶胺衍生物及其醫藥用途
EP3383371A4 (fr) Formulation pharmaceutique
EP3302483A4 (fr) Compositions pharmaceutiques et utilisation de celles-ci
EP3190116A4 (fr) Composé pyrazolothiazole et médicament
LT3601277T (lt) Farmacinė vaisto forma
ZA201607353B (en) Bicyclic derivatives and pharmaceutical composition including the same
IL275144A (en) Pharmacy preparation
EP3134392A4 (fr) Dérivés de sulfonamide et leurs applications pharmaceutiques
EP3233063A4 (fr) Régimes posologiques en trois phases pour l'administration d'antibiotiques en fonction du temps et dispositifs associés
EP3166564A4 (fr) Embout de raccord luer, et dispositifs le comprenant

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20170707

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
A4 Supplementary search report drawn up and despatched

Effective date: 20180426

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/22 20060101AFI20180420BHEP

Ipc: A61P 31/04 20060101ALI20180420BHEP

Ipc: A61K 31/43 20060101ALI20180420BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20181127